EP Patent

EP2486044A2 — Antibacterial aminoglycoside analogs

Assigned to Achaogen Inc · Expires 2012-08-15 · 14y expired

What this patent protects

Compounds having antibacterial activity are disclosed. The compounds have the following structure (I) including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q 1 , Q 2 , Q 5 , R 1 , R 2 , R 3 , Z 1 and Z 2 are as defined herein. Methods associat…

USPTO Abstract

Compounds having antibacterial activity are disclosed. The compounds have the following structure (I) including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q 1 , Q 2 , Q 5 , R 1 , R 2 , R 3 , Z 1 and Z 2 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP2486044A2
Jurisdiction
EP
Classification
—
Expires
2012-08-15
Drug substance claim
No
Drug product claim
No
Assignee
Achaogen Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.